Back to search

Anti-tumour necrosis factor alpha (Infliximab) in the treatment of severe ulcerative colitis: result of an open study on 13 patients

Data up to Jan 2025

Published2002
Citations87
References28

Total Citations Per Year

Abstract

References (28)

A Short-Term Study of Chimeric Monoclonal Antibody cA2 to Tumor Necrosis Factor α for Crohn's Disease

1997 • 3,152 citations

Cortisone in Ulcerative Colitis

1955 • 2,701 citations

Infliximab for the Treatment of Fistulas in Patients with Crohn's Disease

1999 • 2,656 citations

Cyclosporine in Severe Ulcerative Colitis Refractory to Steroid Therapy

1994 • 1,694 citations

Efficacy and safety of retreatment with anti–tumor necrosis factor antibody (infliximab) to maintain remission in Crohn's disease

1999 • 1,107 citations

Endoscopic and histological healing with infliximab anti–tumor necrosis factor antibodies in Crohn's disease: A European multicenter trial

1999 • 755 citations

Serum concentrations of tumour necrosis factor alpha in childhood chronic inflammatory bowel disease.

1991 • 491 citations

Infliximab in the Treatment of Severe, Steroid-Refractory Ulcerative Colitis: A Pilot Study

2001 • 427 citations

Intravenous cyclosporine versus intravenous corticosteroids as single therapy for severe attacks of ulcerative colitis

2001 • 392 citations

Tumor necrosis factor-?, interleukin-1?, and interleukin-6 expression in inflammatory bowel disease

1992 • 325 citations

Interleukin-2- and interferon-gamma-secreting T cells in normal and diseased human intestinal mucosa.

1993 • 324 citations

Infliximab for Crohn's disease in clinical practice at the Mayo Clinic: the first 100 patients

2001 • 296 citations

Mucosal inflammatory cytokine production by intestinal biopsies in patients with ulcerative colitis and Crohn's disease

1996 • 280 citations

Tumour necrosis factor α and interleukin 1β in relapse of Crohn's disease

1999 • 255 citations

ANCA pattern and LTA haplotype relationship to clinical responses to anti-TNF antibody treatment in Crohn's disease

2001 • 224 citations

Increased interleukin-2 messenger RNA in the intestinal mucosal lesions of Crohn's disease but not ulcerative colitis

1992 • 220 citations

A critical review of cyclosporine therapy in inflammatory bowel disease

1995 • 191 citations

Infliximab for refractory ulcerative colitis

2001 • 138 citations

Humanized antibodies for therapy

1991 • 110 citations

Treatment of ulcerative colitis in the cottontop tamarin using antibody to tumour necrosis factor alpha.

1997 • 97 citations

Serum Tumor Necrosis Factor Activity in Inflammatory Bowel Disease

1992 • 80 citations

A randomized, double-blind, placebo-controlled, multi-center trial of the engineered human anti body to TNF (CDP571) for steroid sparing and maintenance of remission in patients with steroid-dependent Crohn's disease

2000 • 78 citations

Clinical and Laboratory Indicators of Extent of Ulcerative Colitis

1988 • 60 citations

Efficacy of Intravenous Cyclosporine for Steroid Refractory Attacks of Ulcerative Colitis

1995 • 56 citations

Short- and long-term efficacy of cyclosporin administration in patients with acute severe ulcerative colitis. Belgian IBD Group.

1997 • 41 citations

The Plain Abdominal Film Accurately Estimates Extent of Active Ulcerative Colitis

1991 • 28 citations

Soluble lnterleukin-2 Receptor, lnterleukin-6 and Interleukin-1 β in Patients with Crohn’s Disease and Ulcerative Colitis: Preoperative Levels and Postoperative Changes of Serum Concentrations

1992 • 27 citations

Infliximab therapy for severe ulcerative colitis refractory to steroid therapy: Report of two cases

2000 • 1 citations

Cited By (0)

Loading...
Anti-tumour necrosis factor alpha (Infliximab) in the treatment of severe ulcerative… (2002) – Digestive and Liver Disease | Metascience Observatory Explorer